专利号:US-12240801-B2 优先权日:2019-06-05 标 题 :Method of synthesis and purification of citrulline 发明人:BULL JAMES ALAN; FISCHER HOLGER CHRISTIAN; KAISER KARL JUERGEN; MONNOT-CHASE BETTE 权利人:ASKLEPION PHARMACEUTICALS LLC 摘要:This invention provides for synthesis of citrulline from a transition metal complex of ornithine using cyanate to derivatize the terminal amino group of ornithine. The invention also provides improved methods for purification of citrulline produced by reaction of cyanate with ornithine via the steps of reprecipitation of copper complex of citrulline, removal of the complexing metal by sulfide precipitation, activated carbon adsorption and antisolvent crystallization.
专利号:WO-9426779-A1 优先权日:1993-05-13 标 题 :PROCESSES AND INTERMEDIATE COMPOUNDS USEFUL FOR THE PREPARATION OF PLATELET GLYCOPROTEIN IIb/IIIa INHIBITORS 发明人:MADUSKUIE THOMAS PETER JR 权利人:DU PONT MERCK PHARMA 摘要:This invention provides processes and intermediates for the synthesis of platelet glycoprotein IIb/IIIa inhibitors of formula (I).
专利号:US-2005192265-A1 优先权日:2003-03-20 标 题:Cycloalkyl, lactam, lactone and related compounds, pharmaceutical compositions comprising same, and methods for inhibiting beta-amyloid peptide release and/or its synthesis by use of such compounds 发明人:THOMPSON RICHARD C; WILKIE STEPHEN; STACK DOUGLAS R; VANMETER ELDON E; SHI QING; BRITTON THOMAS C; AUDIA JAMES E; REEL JON K; MABRY THOMAS E; DRESSMAN BRUCE A; CWI CYNTHIA L; HENRY STEVEN S; MCDANIEL STACEY L; STUCKY RUSSELL D; PORTER WARREN J 摘要:Disclosed are compounds which inhibit β-amyloid peptide release and/or its synthesis, and, accordingly, have utility in treating Alzheimer's disease. Also disclosed are pharmaceutical compositions that include a compound which inhibits β-amyloid peptide release and/or its synthesis as well as methods for treating Alzheimer's disease both prophylactically and therapeutically with such pharmaceutical compositions.
专利号:US-6849650-B2 优先权日:1998-02-27 标 题:Heterocyclic compounds, pharmaceutical compositions comprising same, and methods for inhibiting β-amyloid peptide release and/or its synthesis by use of such compounds 发明人:THORSETT EUGENE D; PORTER WARREN J; NISSEN JEFFREY S; LATIMER LEE H; AUDIA JAMES E; DROSTE JAMES 权利人:ATHENA NEUROSCIENCES INC; LILLY CO ELI 摘要:Disclosed are compounds which inhibit β-amyloid peptide release and/or its synthesis, and, accordingly, have utility in treating Alzheimer's disease. Also disclosed are pharmaceutical compositions comprising a compound which inhibits β-amyloid peptide release and/or its synthesis as well as methods for treating Alzheimer's disease both prophylactically and therapeutically with such pharmaceutical compositions.
专利号:US-6906056-B2 优先权日:1998-06-22 标 题:Cycloalkyl, lactam, lactone and related compounds, pharmaceutical compositions comprising same, and methods for inhibiting β-amyloid peptide release and/or its synthesis by use of such compounds 发明人:THOMPSON RICHARD C; WILKIE STEPHEN; STACK DOUGLAS R; VANMETER ELDON E; SHI QING; BRITTON THOMAS C; AUDIA JAMES E; REEL JON K; MABRY THOMAS E; DRESSMAN BRUCE A; CWI CYNTHIA L; HENRY STEVEN S; MCDANIEL STACEY L; STUCKY RUSSELL D; PORTER WARREN J 权利人:LILLY CO ELI 摘要:Disclosed are compounds which inhibit β-amyloid peptide release and/or its synthesis, and, accordingly, have utility in treating Alzheimer's disease. Also disclosed are pharmaceutical compositions that include a compound which inhibits β-amyloid peptide release and/or its synthesis as well as methods for treating Alzheimer's disease both prophylactically and therapeutically with such pharmaceutical compositions.
专利号:US-7390801-B2 优先权日:1996-12-23 标题:Cycloalkyl, lactam, lactone and related compounds, pharmaceutical compositions comprising same, and methods for inhibiting β-amyloid peptide release and/or its synthesis by use of such compounds 发明人:THORSETT EUGENE D; PLEISS MICHAEL A; LATIMER LEE H; JOHN VARGHESE; FREEDMAN STEPHEN; BRITTON THOMAS C; AUDIA JAMES A; REEL JON K; DRESSMAN BRUCE A; DROSTE JAMES J; HENRY STEVEN S; STUCKY RUSSELL D; PORTER WARREN J 权利人:ATHENA NEUROSCIENCES INC; LILLY CO ELI 摘要:Disclosed are compounds which inhibit β-amyloid peptide release and/or its synthesis, and, accordingly, have utility in treating Alzheimer's disease. Also disclosed are pharmaceutical compositions comprising a compound which inhibits β-amyloid peptide release and/or its synthesis as well as methods for treating Alzheimer's disease both prophylactically and therapeutically with such pharmaceutical compositions.
[参考文献]: Demura S, Et Al. Effect Of L-Ornithine Hydrochloride Ingestion On Intermittent Maximal Anaerobic Cycle Ergometer Performance And Fatigue Recovery After Exercise. Eur J Appl Physiol. 2011 Nov;111(11):2837-43. [参考文献]: Shin S, Et Al. L-Ornithine Activates Ca2+ Signaling To Exert Its Protective Function On Human Proximal Tubular Cells. Cell Signal. 2020 Mar;67:109484. [参考文献]: Andrea Romano, Et Al. Three-Component Lysine/ornithine Decarboxylation System In Lactobacillus Saerimneri 30A. J Bacteriol. 2013 Mar;195(6):1249-54. [参考文献]: Angela Zanatta, Et Al. Disturbance Of Redox Homeostasis By Ornithine And Homocitrulline In Rat Cerebellum: A Possible Mechanism Of Cerebellar Dysfunction In Hhh Syndrome. Life Sci. 2013 Aug 6;93(4):161-8. [参考文献]: Binuraj R K Menon, Et Al. A Conformational Sampling Model For Radical Catalysis In Pyridoxal Phosphate- And Cobalamin-Dependent Enzymes. J Biol Chem. 2014 Dec 5;289(49):34161-74.
合成参考文献
摘要:Journal of Pharmaceutical Sciences., 62(49), 1973 [] 摘要:S13 | EUCOSMETICS | Combined Inventory of Ingredients Employed in Cosmetic Products (2000) and Revised Inventory (2006) | DOI:10.5281/zenodo.2624118 参考文献:10.1007/bf00143389 摘要:Schenkel E, Dubois JG, Helson-Cambier M, Hanocq M. Cytotoxicity of polyamines to Amoeba proteus: role of polyamine oxidase. Cell Biol Toxicol. 1996 Feb;12(1):1–9. doi: 10.1007/bf00143389.